Anti-proliferative activity of 6-O-acyl-D-allose against the human leukemia MOLT-4F cell line

Ryo C Yanagita1, Katsuya Kobashi, Chisa Ogawa

  • 1a Faculty of Agriculture, Department of Applied Biological Science , Kagawa University , Miki-cho , Kagawa , 761-0795 , Japan.

Insights

Researchers investigated D-allose derivatives for anti-leukemia activity. The 6-O-dodecanoyl derivative showed significantly enhanced anti-proliferative effects against MOLT-4F cells, highlighting the importance of pyranose forms.

Area of Science:

  • Biochemistry
  • Organic Chemistry
  • Pharmacology

Background:

  • D-allose is a rare monosaccharide with potential biological activities.
  • Leukemia remains a significant health concern, necessitating novel therapeutic agents.
  • Acyl derivatives of sugars are explored for modified biological properties.

Purpose of the Study:

  • To synthesize and evaluate the anti-proliferative activities of 6-O-acyl derivatives of D-allose.
  • To identify specific derivatives with enhanced anti-leukemic potential.
  • To determine the structural requirements for anti-proliferative activity.

Main Methods:

  • Synthesis of various 6-O-acyl derivatives of D-allose.
  • In vitro anti-proliferative assays using the human leukemia MOLT-4F cell line.
  • Structure-activity relationship analysis, comparing pyranose and furanose forms.

Main Results:

  • The 6-O-dodecanoyl derivative of D-allose exhibited potent anti-proliferative activity.
  • This derivative demonstrated approximately 30-fold increased activity compared to native D-allose.
  • The pyranose form of the 6-O-dodecanoyl derivative was crucial for its anti-proliferative efficacy, whereas furanose forms were less active.

Conclusions:

  • 6-O-acyl derivatives of D-allose, particularly the dodecanoyl derivative, possess significant anti-leukemic properties.
  • The anti-proliferative activity is dependent on the specific acyl chain and the sugar ring conformation (pyranose form).
  • These findings suggest potential for developing novel D-allose-based anti-cancer agents.

Related Concept Videos